Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

PIERIS PHARMACEUTICALS INC (PIRS)

Pharmaceutical Preparations

https://www.pieris.com

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States.

225 FRANKLIN STREET, 26TH FLOOR
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/23/2014

Market Cap

21,519,912

Shares Outstanding

98,850,000

Weighted SO

98,851,927

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ADAP --.--%

MREO --.--%

PDSB --.--%

LPTX --.--%

XFOR --.--%

CRVS --.--%

TERN --.--%

TCRR --.--%

AFMD --.--%

Beta

0.6800

Last Div

0.0000

Range

6.2-41.76

Chg

0.0300

Avg Vol

133241

Mkt Cap

21519912

Exch

NASDAQ

Country

US

Phone

857 246 8998

DCF Diff

21.1498

DCF

-9.5198

Div Yield

0.0000

P/S

1.0310

EV Multiple

0.5152

P/FV

1.1320

Div Yield %

0.0000

P/E

-0.8890

PEG

-0.1951

Payout

0.0000

Current Ratio

3.9475

Quick Ratio

3.9475

Cash Ratio

3.1092

DSO

81.6843

DIO

0.0000

Op Cycle

81.6843

DPO

68.5038

CCC

13.1805

Gross Margin

0.7526

Op Margin

-1.2825

Pretax Margin

-1.1411

Net Margin

-1.1411

Eff Tax Rate

-0.5698

ROA

-0.9508

ROE

-0.9728

ROCE

-1.4311

NI/EBT

1.0000

EBT/EBIT

0.8898

EBIT/Rev

-1.2825

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-11.4987

CF/Debt

0.0000

Equity Multi

1.3393

Rec Turnover

4.4684

Pay Turnover

5.3282

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.8332

OCF/Share

-29.1517

FCF/Share

-29.1948

Cash/Share

15.1894

OCF/Sales

-1.8143

FCF/OCF

1.0015

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-676.2143

Div&CapEx Cov

-676.2143

P/BV

1.1320

P/B

1.1320

P/S

1.0310

P/E

-0.8890

P/FCF

-0.5674

P/OCF

-0.5591

P/CF

-0.5591

PEG

-0.1951

P/S

1.0310

EV Multiple

0.5152

P/FV

1.1320

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation